Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
AssigneeCompass Pathfinder Limited
InventorsDerek John LONDESBROUGH, Christopher BROWN, Julian Scott NORTHEN, Gillian MOORE, Hemant Kashinath PATIL, David E. NICHOLS
Life of this patent
Estimating the term…
Abstract
This invention relates to the large-scale production of psilocybin for use in medicine. More particularly, it relates to a method of obtaining high purity crystalline psilocybin, particularly, in the form of Polymorph A. It further relates to a method for the manufacture of psilocybin and intermediates in the production thereof and formulations containing psilocybin.
Claims22
1-28. (canceled)
A compound having the following structure:
Crystalline psilocybin having no single impurity greater than 1% prepared by recrystallization of psilocybin from water at a temperature not greater than about 80° C.
A method for manufacturing crystalline psilocybin, the method comprising:
- i) reacting psilocin with tetrabenzylpyrophosphate to form benzyl 3-[2-(benzyldimethylazaniumyl)ethyl]-1H-indol-4-yl phosphate;
- ii) reacting the benzyl 3-[2-(benzyldimethylazaniumyl)ethyl]-1H-indol-4-yl phosphate with hydrogen in the presence of a catalyst to form psilocybin;
- and
- iii) crystallizing the psilocybin from water at a temperature not greater than about 80° C. to obtain the crystalline psilocybin.
Dependencies are inferred from the claim text.